Myasthenia gravis: lung-function studies without and with edrophonium chloride

Area of Science:

• Neurology
• Pulmonology
• Pharmacology

Background:

• Myasthenia gravis (MG) is a neuromuscular disorder affecting voluntary muscles.
• Respiratory muscle weakness is a critical manifestation of MG, particularly during crisis.
• Assessing respiratory function is crucial for managing MG patients.

Purpose of the Study:

• To evaluate respiratory function in MG patients.
• To assess the impact of Tensilon (edrophonium chloride) on respiratory parameters.
• To identify potential benefits and side effects of Tensilon in MG.

Main Methods:

• Investigated 25 MG patients (14 crisis-endangered, 11 not endangered).
• Measured vital capacity and forced respiratory function parameters.
• Observed respiratory parameter changes after intravenous Tensilon administration.

Main Results:

• MG patients exhibited significantly lower vital capacity and forced respiratory parameters compared to predicted values.
• Maximal inspiratory flows showed the most significant reduction.
• Tensilon administration increased pathologically reduced maximal inspiratory flows.
• Tensilon also increased respiratory flow resistance and decreased maximal expiratory flows, suggesting potential bronchoconstriction.

Conclusions:

• Tensilon's positive effect on inspiratory flows may indicate respiratory muscle improvement or undertreatment in MG.
• Tensilon's potential to cause bronchoconstriction and increase airway resistance limits its use in MG crisis, especially with co-existing obstructive lung disease.